• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏转流瓣膜置换术后并存主动脉瓣狭窄和甲状腺素运载蛋白心脏淀粉样变性的逆向重构。

Reverse Remodeling Following Valve Replacement in Coexisting Aortic Stenosis and Transthyretin Cardiac Amyloidosis.

机构信息

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Austria (C.N., M.K., C.D., R. Radun, K.M., A.K., G.H., V.D., G.S., K.H., M.-P.W., R. Rosenhek, P.B., C.H., J.M., G.G.).

Division of Nuclear Medicine (R.C., M.H.), Medical University of Vienna.

出版信息

Circ Cardiovasc Imaging. 2022 Jul;15(7):e014115. doi: 10.1161/CIRCIMAGING.122.014115. Epub 2022 Jul 8.

DOI:10.1161/CIRCIMAGING.122.014115
PMID:35861981
Abstract

BACKGROUND

Dual pathology of severe aortic stenosis (AS) and transthyretin cardiac amyloidosis (ATTR) is increasingly recognized. Evolution of symptoms, biomarkers, and myocardial mechanics in AS-ATTR following valve replacement is unknown. We aimed to characterize reverse remodeling in AS-ATTR and compared with lone AS.

METHODS

Consecutive patients referred for transcatheter aortic valve replacement (TAVR) underwent ATTR screening by blinded 99mTc-DPD bone scintigraphy (Perugini Grade-0 negative, 1-3 increasingly positive) before intervention. ATTR was diagnosed by DPD and absence of monoclonal protein. Reverse remodeling was assessed by comprehensive evaluation before TAVR and at 1 year.

RESULTS

One hundred twenty patients (81.8±6.3 years, 51.7% male, 95 lone AS, 25 AS-ATTR) with complete follow-up were studied. At 12 months (interquartile range, 7-17) after TAVR, both groups experienced significant symptomatic improvement by New York Heart Association functional class (both <0.001). Yet, AS-ATTR remained more symptomatic (New York Heart Association ≥III: 36.0% versus 13.8; =0.01) with higher residual NT-proBNP (N-terminal pro-brain natriuretic peptide) levels (<0.001). Remodeling by echocardiography showed left ventricular mass regression only for lone AS (=0.002) but not AS-ATTR (=0.5). Global longitudinal strains improved similarly in both groups. Conversely, improvement of regional longitudinal strain showed a base-to-apex gradient in AS-ATTR, whereas all but apical segments improved in lone AS. This led to the development of an apical sparing pattern in AS-ATTR only after TAVR.

CONCLUSIONS

Patterns of reverse remodeling differ from lone AS to AS-ATTR, with both groups experiencing symptomatic improvement by TAVR. After AS treatment, AS-ATTR transfers into a lone ATTR cardiomyopathy phenotype.

摘要

背景

严重主动脉瓣狭窄(AS)和转甲状腺素蛋白心脏淀粉样变性(ATTR)的双重病变越来越受到关注。在接受瓣膜置换术后,AS-ATTR 的症状、生物标志物和心肌力学的演变尚不清楚。我们旨在对 AS-ATTR 的逆向重构进行特征描述,并与单纯 AS 进行比较。

方法

连续接受经导管主动脉瓣置换术(TAVR)的患者在介入前通过盲法 99mTc-DPD 骨闪烁显像进行 ATTR 筛查(佩鲁基尼分级-0 为阴性,1-3 级逐渐阳性)。通过 DPD 和无单克隆蛋白诊断 ATTR。在 TAVR 前和 1 年后通过综合评估来评估逆向重构。

结果

共研究了 120 例患者(81.8±6.3 岁,51.7%为男性,95 例为单纯 AS,25 例为 AS-ATTR),且均完成了随访。在 TAVR 后 12 个月(四分位间距,7-17),两组患者的纽约心功能分级(均<0.001)均有明显改善。然而,AS-ATTR 的症状仍更为严重(纽约心功能分级≥III:36.0%比 13.8%;=0.01),且残余 NT-proBNP(N 端脑钠肽前体)水平更高(<0.001)。超声心动图显示,只有单纯 AS 出现左心室质量的回归(=0.002),而 AS-ATTR 没有(=0.5)。两组的整体纵向应变均得到改善。相反,在 AS-ATTR 中,区域性纵向应变的改善呈基底到心尖的梯度,而在单纯 AS 中,除心尖段外,所有节段均得到改善。这导致仅在 TAVR 后,AS-ATTR 出现心尖部保留模式。

结论

与单纯 AS 相比,AS-ATTR 的逆向重构模式不同,两组患者在接受 TAVR 后症状均有改善。在 AS 治疗后,AS-ATTR 转化为单纯的 ATTR 心肌病表型。

相似文献

1
Reverse Remodeling Following Valve Replacement in Coexisting Aortic Stenosis and Transthyretin Cardiac Amyloidosis.心脏转流瓣膜置换术后并存主动脉瓣狭窄和甲状腺素运载蛋白心脏淀粉样变性的逆向重构。
Circ Cardiovasc Imaging. 2022 Jul;15(7):e014115. doi: 10.1161/CIRCIMAGING.122.014115. Epub 2022 Jul 8.
2
Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement.揭示老年重度主动脉瓣狭窄行经导管主动脉瓣置换术患者中的转甲状腺素蛋白心脏淀粉样变性及其预测因素。
Eur Heart J. 2017 Oct 7;38(38):2879-2887. doi: 10.1093/eurheartj/ehx350.
3
Amyloid Transthyretin Cardiomyopathy in Elderly Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation.老年主动脉瓣狭窄行经导管主动脉瓣置换术患者的转甲状腺素蛋白淀粉样变心肌病。
J Am Heart Assoc. 2023 Aug 15;12(16):e030271. doi: 10.1161/JAHA.123.030271. Epub 2023 Aug 10.
4
Transthyretin cardiac amyloidosis in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement: experience of a single center.严重主动脉瓣狭窄患者经导管主动脉瓣置换术中的转甲状腺素蛋白心脏淀粉样变性:单中心经验
Minerva Cardiol Angiol. 2024 Feb;72(1):87-94. doi: 10.23736/S2724-5683.23.06175-6. Epub 2023 Jul 5.
5
Routine 4D Cardiac CT to Identify Concomitant Transthyretin Amyloid Cardiomyopathy in Older Adults with Severe Aortic Stenosis.常规 4D 心脏 CT 识别老年严重主动脉瓣狭窄患者合并转甲状腺素蛋白淀粉样心肌病。
Radiology. 2023 Dec;309(3):e230425. doi: 10.1148/radiol.230425.
6
Cardiac amyloidosis prevalence and 1-year outcome in patients with aortic stenosis undergoing transaortic valve implantation: Findings from the CAMPOS-TAVI study.经主动脉瓣植入术治疗的主动脉瓣狭窄患者中心脏淀粉样变性的患病率和 1 年转归:CAMPOS-TAVI 研究的结果。
Arch Cardiovasc Dis. 2024 Aug-Sep;117(8-9):461-469. doi: 10.1016/j.acvd.2024.04.007. Epub 2024 Aug 8.
7
Impact of afterload and infiltration on coexisting aortic stenosis and transthyretin amyloidosis.后负荷及浸润对并存的主动脉瓣狭窄和转甲状腺素蛋白淀粉样变性的影响。
Heart. 2022 Jan;108(1):67-72. doi: 10.1136/heartjnl-2021-319922. Epub 2021 Sep 8.
8
Unveiling outcomes in coexisting severe aortic stenosis and transthyretin cardiac amyloidosis.揭示并存严重主动脉瓣狭窄和转甲状腺素蛋白心脏淀粉样变性的结果。
Eur J Heart Fail. 2021 Feb;23(2):250-258. doi: 10.1002/ejhf.1974. Epub 2020 Sep 8.
9
In the midst of a dangerous intersection with unclear therapeutic strategies: a challenging case of severe aortic stenosis.在治疗策略不明确的危险十字路口:一例严重主动脉瓣狭窄的挑战性病例。
BMC Cardiovasc Disord. 2020 Jun 1;20(1):261. doi: 10.1186/s12872-020-01533-x.
10
Prevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac Amyloidosis.并存的主动脉瓣狭窄和心脏淀粉样变性的患病率和结局。
J Am Coll Cardiol. 2021 Jan 19;77(2):128-139. doi: 10.1016/j.jacc.2020.11.006. Epub 2020 Nov 9.

引用本文的文献

1
A Tale of Two Diseases: Decoding Aortic Stenosis and Cardiac Amyloidosis.两种疾病的故事:解读主动脉瓣狭窄与心脏淀粉样变
J Clin Med. 2025 Apr 12;14(8):2652. doi: 10.3390/jcm14082652.
2
Coexisting Calcific Aortic Stenosis and Transthyretin Cardiac Amyloidosis: Real-World Evaluation of Clinical Characteristics and Outcomes.并存的钙化性主动脉瓣狭窄与转甲状腺素蛋白心脏淀粉样变:临床特征与结局的真实世界评估
J Am Heart Assoc. 2025 Jan 21;14(2):e033251. doi: 10.1161/JAHA.123.033251. Epub 2025 Jan 16.
3
Utilizing artificial intelligence to detect cardiac amyloidosis in patients with severe aortic stenosis: A step forward to diagnose the underdiagnosed.
利用人工智能检测重度主动脉瓣狭窄患者的心脏淀粉样变性:向诊断未得到充分诊断的疾病迈进了一步。
Eur J Nucl Med Mol Imaging. 2025 Jan;52(2):482-484. doi: 10.1007/s00259-024-06928-y.
4
Reverse Left Ventricular Remodeling With Transcatheter Interventions in Chronic Heart Failure Syndromes: An Updated Appraisal of the Device Landscape.慢性心力衰竭综合征经导管介入治疗后的左心室逆向重塑:器械领域的最新评估
J Soc Cardiovasc Angiogr Interv. 2023 Dec 4;2(6Part B):101196. doi: 10.1016/j.jscai.2023.101196. eCollection 2023 Nov-Dec.
5
The Relative Apical Sparing Strain Pattern in Severe Aortic Valve Stenosis: A Marker of Adverse Cardiac Remodeling.重度主动脉瓣狭窄中的相对心尖保留应变模式:心脏不良重塑的一个标志物。
J Pers Med. 2024 Jul 1;14(7):707. doi: 10.3390/jpm14070707.
6
TAVR in Older Adults: Moving Toward a Comprehensive Geriatric Assessment and Away From Chronological Age: Family Series.老年患者的经导管主动脉瓣置换术:迈向全面老年综合评估并摒弃实际年龄:家庭系列研究
JACC Adv. 2024 Apr;3(4). doi: 10.1016/j.jacadv.2024.100877. Epub 2024 Apr 8.
7
Screening for Occult Transthyretin Amyloidosis in Patients with Severe Aortic Stenosis and Amyloid Red Flags.对患有严重主动脉瓣狭窄且有淀粉样变警示信号的患者进行隐匿性转甲状腺素蛋白淀粉样变筛查。
J Clin Med. 2024 Jan 24;13(3):671. doi: 10.3390/jcm13030671.
8
Cardiac Amyloidosis and Valvular Heart Disease.心脏淀粉样变性与心脏瓣膜病
J Clin Med. 2023 Dec 30;13(1):221. doi: 10.3390/jcm13010221.
9
Cardiac amyloidosis and aortic stenosis: a state-of-the-art review.心脏淀粉样变性与主动脉瓣狭窄:最新综述
Eur Heart J Open. 2023 Oct 12;3(6):oead106. doi: 10.1093/ehjopen/oead106. eCollection 2023 Nov.
10
Valvular heart disease in patients with cardiac amyloidosis.心脏淀粉样变患者的瓣膜性心脏病。
Heart Fail Rev. 2024 Jan;29(1):65-77. doi: 10.1007/s10741-023-10350-1. Epub 2023 Sep 22.